Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 362

    1.

    Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.

    Fabris B, Candido R, Carraro M, Fior F, Artero M, Zennaro C, Cattin MR, Fiorotto A, Bortoletto M, Millevoi C, Bardelli M, Faccini L, Carretta R.

    Diabetes. 2001 Nov;50(11):2619-24.PMID: 11679443 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.

    Petitjean P, Vloemans M, Barthelmebs M, Stephan D, Grima M, Jund A, Imbs JL.

    Fundam Clin Pharmacol. 1994;8(4):356-65.PMID: 7851841 [PubMed - indexed for MEDLINE]Related articles

    3.

    ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.

    Ono H, Ono Y, Frohlich ED.

    Hypertension. 1996 Feb;27(2):176-83.PMID: 8567038 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.

    Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M, Campanacci L, Carretta R.

    J Hypertens. 1999 Dec;17(12 Pt 2):1925-31.PMID: 10703891 [PubMed - indexed for MEDLINE]Related articles

    5.

    Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.

    Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O, Hamon G, Bariety J, Bruneval P.

    Lab Invest. 1995 Jul;73(1):64-71.PMID: 7603042 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.

    Perico N, Amuchastegui SC, Colosio V, Sonzogni G, Bertani T, Remuzzi G.

    J Am Soc Nephrol. 1994 Oct;5(4):1139-46.PMID: 7849255 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Angiotensin-converting enzyme inhibition in adult hypertensive rats: a stereological study of renal filtration surface area.

    Dunstan HJ, Briscoe TA, Bertram JF, Johnston CI, Black MJ.

    Clin Exp Pharmacol Physiol. 2003 Jan-Feb;30(1-2):72-6.PMID: 12542457 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.

    Mukawa H, Toki Y, Shimauchi A, Matsui H, Morishima I, Okumura K, Ito T, Hayakawa T.

    J Hypertens. 1997 Sep;15(9):1027-32.PMID: 9321751 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.

    Jandeleit-Dahm K, Lassila M, Davis BJ, Candido R, Johnston CI, Allen TJ, Burrell LM, Cooper ME.

    J Hypertens. 2005 Nov;23(11):2071-82.PMID: 16208151 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.

    Graziano MJ, Dethloff LA, Griffin HE, Pegg DG.

    Arch Int Pharmacodyn Ther. 1993 Jul-Aug;324:87-104.PMID: 8297189 [PubMed - indexed for MEDLINE]Related articles

    11.

    Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.

    New JP, Canavan JP, Flyvbjerg A, Hamon G, Bilous RW, Marshall SM.

    Diabetologia. 1996 Feb;39(2):166-71.PMID: 8635668 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.

    Erensoy N, Yilmazer S, Oztürk M, Tunçdemir M, Uysal O, Hatemi H.

    Acta Histochem. 2004;106(4):279-87.PMID: 15350810 [PubMed - indexed for MEDLINE]Related articles

    13.

    ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.

    Gross ML, El-Shakmak A, Szábó A, Koch A, Kuhlmann A, Münter K, Ritz E, Amann K.

    Diabetologia. 2003 Jun;46(6):856-68. Epub 2003 Jun 11.PMID: 12802493 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.

    Sen S, Kanter M, Ustundag S, Aktas C, Dogutan H, Yalcin O.

    Ren Fail. 2008;30(10):1023-33. Erratum in: Ren Fail. 2009;31(2):180. Saniye, Sen [corrected to Sen, Saniye]; Mehmet, Kanter [corrected to Kanter, Mehmet]; Sedat, Ustundag [corrected to Ustundag, Sedat]; Cevat, Aktas [corrected to Aktas, Cevat]; Omer, Yalcin [corrected to Yalcin, Omer]. PMID: 19016156 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats.

    Taniguchi M, Kim S, Zhan Y, Iwao H.

    Hypertens Res. 2002 Mar;25(2):287-94.PMID: 12047045 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.

    Hill C, Logan A, Smith C, Grønbaek H, Flyvbjerg A.

    Diabetologia. 2001 Apr;44(4):495-500.PMID: 11357481 [PubMed - indexed for MEDLINE]Related articles

    17.

    Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus.

    Carraro M, Mancini W, Artero M, Zennaro C, Faccini L, Candido R, Armini L, Calci M, Carretta R, Fabris B.

    Diabetologia. 2000 Feb;43(2):235-41.PMID: 10753047 [PubMed - indexed for MEDLINE]Related articles

    18.

    Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.

    Blanco S, Vaquero M, Gómez-Guerrero C, López D, Egido J, Romero R.

    Am J Hypertens. 2005 Apr;18(4 Pt 1):557-65.PMID: 15831368 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.

    Onozato ML, Tojo A, Goto A, Fujita T.

    Diabetes Res Clin Pract. 2003 Feb;59(2):83-92. Erratum in: Diabetes Res Clin Pract. 2003 Jun;60(3):217. PMID: 12560157 [PubMed - indexed for MEDLINE]Related articles

    20.

    [ACE inhibitor effects on structure and function of the glomerular basement membrane]

    Hasslacher C, Bostedt-Kiesel A, Kempe HP.

    Klin Wochenschr. 1992;69 Suppl 29:39-44. Review. German. PMID: 1614191 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data